People · Operator
Named in public records as an officer, director or promoter · active 2014–2014 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Farapulse, Inc. | — | Biotechnology | Series A | $36.3M | $433.8M | 2014 |
David P. Jacques at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David P. Jacques on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Weisskoff | 1 | 12 |
| Andrew ElBardissi | 1 | 7 |
| James Eadie | 1 | 6 |
| Christopher Kaster | 1 | 5 |
| Chris Kaster | 1 | 3 |
| Allan Zingeler | 1 | 2 |
| Craig P. Colmar | 1 | 2 |
| Steven Richard Mickelsen | 1 | 1 |
| Howard Richard Dittrich | 1 | 1 |
| John P. Slump | 1 | 1 |
| David P. Booth | 1 | 1 |
| Raju P. Viswanathan | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.